Comments

TransCode Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does TransCode Therapeutics (RNAZ) operate in?

TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

RNAZNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Why is it moving?

TransCode Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.

TransCode Therapeutics Inc is expected to split Thursday, May 15, 2025 with a ratio of 1:28

Q1 2025 Earnings were released on Wed May 14th, before the market open

TransCode Therapeutics (RNAZ) Forecast

News Earnings TransCode Therapeutics (RNAZ) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

TransCode Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:RNAZ | Benzinga

Explore TransCode Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RNAZ.

Open	$8.25
Close	-
Volume / Avg.	140.94K / 325.43K
Day Range	$7.19 - $8.99
52 Wk Range	6.15 - 1.84K
Market Cap	$178.21M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	4.89%
Days to Cover	1

Recent News

US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert

U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Futures of benchmark indices were lower in premarket.

Rishabh Mishra

Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Tyson Foods, Ford And 3 Stocks To Watch Heading Into Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.25
Close	-
Volume / Avg.	140.94K / 325.43K
Day Range	$7.19 - $8.99
52 Wk Range	6.15 - 1.84K
Market Cap	$178.21M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	4.89%
Days to Cover	1

About TransCode Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing ...

Got Questions? Ask

What is RNAZ's all-time high price?

What is RNAZ's max drawdown this year?

What is RNAZ's operating cash flow?

What is the consensus rating for RNAZ?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy TransCode Therapeutics (RNAZ) stock?

You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.

View our list of the best stock brokerages

Who are TransCode Therapeutics (RNAZ) competitors?

Other companies in TransCode Therapeutics’s space includes: Monopar Therapeutics (NASDAQ:MNPR), Tevogen Bio Holdings (NASDAQ:TVGN), Monte Rosa Therapeutics (NASDAQ:GLUE), Neurogene (NASDAQ:NGNE) and Genfit (NASDAQ:GNFT).

What is the forecast, or price target, for TransCode Therapeutics (RNAZ) stock?

TransCode Therapeutics has a consensus price target of $10.00.

What is the current price for TransCode Therapeutics (RNAZ)?

The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $7.635 last updated May 15, 2025 at 12:59 PM EDT.

Does TransCode Therapeutics (RNAZ) pay a dividend?

There are no upcoming dividends for TransCode Therapeutics.

When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?

TransCode Therapeutics’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is TransCode Therapeutics (RNAZ) going to split?

There is no upcoming split for TransCode Therapeutics.

What sector and industry does TransCode Therapeutics (RNAZ) operate in?

TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.